Skip to Main content Skip to Navigation
New interface
Journal articles

Has tumor doubling time in breast cancer changed over the past 80 years? A systematic review

Abstract : Over the past century, epidemiologic changes and implementation of screening may have had an impact on tumor doubling time in breast cancer. Our study was designed to evaluate changes in tumor doubling time in breast cancer over the past 80 years. A systematic review of published literature and meta-regression analysis was performed. An online electronic database search was undertaken using the PubMed platform from inception until June 2020. All studies that measured tumor doubling time in breast cancer were included. A total of 151 publications were retrieved. Among them, 16 full-text articles were included in the qualitative analysis. An exponential growth model was used for quantitative characterization of tumor growth rate. Tumor doubling time has remained stable over the past 80 years. Recent studies have not only identified “fast growing tumor” (grade 3, human epidermal growth factor receptor 2-positive, triple-negative, or tumor with an elevated Ki-67) but also “inactive breast cancer” feeding the ongoing debate of overdiagnosis due to screening programs. The stability of tumor doubling time over the past 80 years, despite increasing and changing risk factors, supports the validity for our screening guidelines. Prospective studies based on more precise measurement of tumor size and adjustment for tumor characteristics are necessary to more clearly characterize the prognostic and predictive impact of tumor doubling time in breast cancer.
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03401848
Contributor : Équipe HAL UVSQ Connect in order to contact the contributor
Submitted on : Monday, May 30, 2022 - 3:30:28 PM
Last modification on : Saturday, October 22, 2022 - 5:01:23 AM
Long-term archiving on: : Wednesday, August 31, 2022 - 6:55:41 PM

File

CAM4-10-5203.pdf
Publication funded by an institution

Identifiers

Citation

Méryl Dahan, Delphine Hequet, Claire Bonneau, Xavier Paoletti, Roman Rouzier. Has tumor doubling time in breast cancer changed over the past 80 years? A systematic review. Cancer Medicine, 2021, 10 (15), pp.5203-5217. ⟨10.1002/cam4.3939⟩. ⟨hal-03401848⟩

Share

Metrics

Record views

33

Files downloads

41